Ambrisentan for Treatment of Portopulmonary Hypertension (Q64637406)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ambrisentan for Treatment of Portopulmonary Hypertension |
clinical trial |
Statements
Ambrisentan for Treatment of Portopulmonary Hypertension (PoPH): a Pilot Study (English)
0 references
July 2012
0 references
April 2016
0 references
0
0 references
18 year
0 references